Alexandru Stieber/LinkedIn
Dec 1, 2025, 15:32
Alexandru Stieber on a Curious Finding: GLP-1 RAs and the Risk of Optic Neuropathy
Alexandru Stieber, Internal Medicine Resident at SUUMC Bucharest, posted on LinkedIn:
“A very curious research revealing a possible link between the use of GLP-1 receptor antagonists such as semaglutide or liraglutide and the risk of developing nonarteritic ischemic anterior optic neuropathy, current findings which support previous studies on the matter and that nuance the uses of such therapeutic agents.”
Title: GLP-1 RAs and Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Older Patients With Diabetes
Authors: Kin Wah Fung, Fitsum Baye, Seo H. Baik, Clement J. McDonald
Read full article here.
Stay updated with Hemostasis Today.
-
Aug 15, 2026, 19:30José Luis Neyro: E4 and DRSP Reduce Hirsutism While Showing Comparable Effects on Thrombin Generation
-
Aug 15, 2026, 19:27Mahmoud Akraym: Don’t Choose Anticoagulation as the Immediate Treatment for Unstable AF
-
Aug 15, 2026, 19:25Ahmed Bennis: DOACs Increase 1-Year Stroke Risk but Reduce MI Risk Compared With Warfarin
-
Aug 15, 2026, 19:24Megan Adediran: An Unwavering Fight for People Living With Haemophilia
-
Aug 15, 2026, 19:23Intravenous Anticoagulation Linked to Worse Early Outcomes After Noncardioembolic Stroke – International Journal of Stroke
-
Aug 15, 2026, 18:03Alejandro González Veliz: Pulmonary Embolism Is Not Always an Anticoagulation-Only Problem
-
Aug 15, 2026, 17:57Ayesha Zia: A New Foundation for Pediatric Pulmonary Embolism Research and Care
-
Aug 15, 2026, 17:50Muhammad Shaheer Bin Faheem: 25 Years of Thromboembolism and Hypertension Mortality
-
Aug 15, 2026, 17:21Bilal Salman։ NETosis as a Therapeutic Target in Inflammation and Thrombosis